Trademark Attorney / Law Firm
Catherine Benson – Trademark Portfolio
Catherine Benson specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 5 of 6 total filings concentrated in this category. The practice also covers Class 1 (Chemicals) along with 4 other Nice Classification classes. Filing activity spans from 2013 to 2021. Currently, 2 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Catherine Benson's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademark applications has Catherine Benson filed?
Catherine Benson has filed 6 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 2 registered, 3 abandoned, 1 cancelled.
What trademark classes does Catherine Benson specialize in?
Catherine Benson has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
How long has Catherine Benson been filing trademarks?
Catherine Benson's trademark filing history with the USPTO spans from 2013 to 2021, covering 8 years of trademark practice. During this period, Catherine Benson has handled 6 trademark applications.
What is Catherine Benson's trademark registration success rate?
Catherine Benson has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.